Soluble Epoxide Hydrolase (sEH): A Novel Therapeutic Target in Mitigating the Symptoms of Parkinson’s Disease
Pharmacognosy Reviews · 03.08.2026 · 20 (40) · 154-169
DOI: 10.5530/phrev.20260004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacognosy Reviews, online erschienen am 03.08.2026. Verfasst von Richa Mehta und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mehta, R., Nair, S., Manjunath, S., Manjula, S. N., Ramesh, G., Gunasekaran, S. K., Gavisiddaiah, M., & Mali, P. Y. (2026). Soluble Epoxide Hydrolase (sEH): A Novel Therapeutic Target in Mitigating the Symptoms of Parkinson’s Disease. Pharmacognosy Reviews, 20(40), 154-169. https://doi.org/10.5530/phrev.20260004
Vancouver
Mehta R, Nair S, Manjunath S, Manjula SN, Ramesh G, Gunasekaran SK, et al. Soluble Epoxide Hydrolase (sEH): A Novel Therapeutic Target in Mitigating the Symptoms of Parkinson’s Disease. Pharmacognosy Reviews. 2026;20(40):154-169. doi:10.5530/phrev.20260004
BibTeX
@article{Mehta2026,
author = {Mehta, Richa and Nair, Salini and Manjunath, Sahyadri and Manjula, Santhepete Nanjundaiah and Ramesh, Gokul and Gunasekaran, Sathish Kumar and Gavisiddaiah, Mamatha and Mali, Prashant Yuvaraj},
title = {Soluble Epoxide Hydrolase (sEH): A Novel Therapeutic Target in Mitigating the Symptoms of Parkinson’s Disease},
journal = {Pharmacognosy Reviews},
year = {2026},
volume = {20},
number = {40},
pages = {154--169},
doi = {10.5530/phrev.20260004}
}
EUVIMED